Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency
about
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to dateThe challenges of introducing routine G6PD testing into radical cure: a workshop report.Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in CambodiaHaemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.Primaquine treatment and relapse in Plasmodium vivax malariaPrevalence of G6PD deficiency and Plasmodium falciparum parasites in asymptomatic school children living in southern Ghana.Single-Dose Primaquine in a Preclinical Model of Glucose-6-Phosphate Dehydrogenase Deficiency: Implications for Use in Malaria Transmission-Blocking Programs.Management of relapsing Plasmodium vivax malariaPlasmodium vivax Malaria in Cambodia.Modelling primaquine-induced haemolysis in G6PD deficiency.Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies.Adverse neuropsychiatric effects of antimalarial drugs.Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.Dihydroartemisinin induces autophagy-dependent death in human tongue squamous cell carcinoma cells through DNA double-strand break-mediated oxidative stress.Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyondSingle low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.Diagnosis and Treatment of Plasmodium vivax Malaria.Prevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals.Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis
P2860
Q26741307-12ED332F-A712-4D03-8D0A-921A2F5A6016Q30666192-C00A3355-D569-4C6D-B509-CCA3518C62F2Q35976692-6D3C37A6-DDB5-41B2-A399-3E17D3F75092Q36175374-07F1E13A-E8C2-4157-A736-52E57513355FQ36272772-D615B895-77A1-4141-9D21-883639DDB7E3Q36909121-397A0340-193E-437B-BCE3-CEF07AD3A409Q37125793-1F5D3873-7618-47BB-A744-3959C4A935E1Q37287860-E4ABFB76-ED4B-4D76-829D-439252FA62A7Q37290599-B68BA63D-98FD-4986-B034-B3098DF6F98CQ37546209-F6809689-0340-416F-82E9-73A5294E7B24Q37672066-62ED4AF8-2EE2-4EFF-A19E-2043364F9F35Q38613700-BC1759CA-95B0-4613-A753-80AC6AD38495Q38808162-F6CE9832-0B70-4CB6-9DC8-F650B4D55A98Q39413284-FCD9AA03-447E-4C79-A26A-2FF0AD4DCC09Q41233873-DD9DB45F-C5F6-4D19-8875-15E6390CE7A6Q42632539-CF0F202C-CA7D-46B2-B7DF-2A0BAEA62D55Q48022479-25EB7FAC-18ED-4AC8-AFE2-2C4FA0D744A0Q53701213-A1FC9E58-6DD3-4EC3-90B0-72EABDCF78DDQ53767337-D7F8C623-B999-4219-8D5B-A57FE0D082A2Q55012522-DF58CFD7-4475-4453-B003-9D78B2DBC78AQ55212289-57C2DF76-50E1-4F9F-A675-986E56D0688AQ56352635-0A6D744A-086B-4982-A40D-FD7CE8B6CB43
P2860
Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tolerability and safety of wee ...... phate dehydrogenase deficiency
@ast
Tolerability and safety of wee ...... phate dehydrogenase deficiency
@en
type
label
Tolerability and safety of wee ...... phate dehydrogenase deficiency
@ast
Tolerability and safety of wee ...... phate dehydrogenase deficiency
@en
prefLabel
Tolerability and safety of wee ...... phate dehydrogenase deficiency
@ast
Tolerability and safety of wee ...... phate dehydrogenase deficiency
@en
P2093
P2860
P921
P1433
P1476
Tolerability and safety of wee ...... phate dehydrogenase deficiency
@en
P2093
Alexandra Kerleguer
Chan Vanna
Chuor Meng Char
Eva Christophel
John K Baird
Khem Kosal
Khon Sothea
Narann Tops
Pascal Ringwald
P2860
P2888
P356
10.1186/S12916-015-0441-1
P407
P577
2015-08-25T00:00:00Z